Pressure Lowering Medications

摘要: Glaucoma is an irreversible chronic disease; thus, management a great challenge. The main goal of treatment to prevent further nerve fibre damage. present modes include pressure-lowering medications, laser treatment, and surgical interventions, all which aim reduce IOP. Diversion aqueous humour outflow through iatrogenic fistula the sub-conjunctival space principle underlying glaucoma surgery. Surgical intervention provides sustainable constant IOP reduction but not without intraand postoperative complications (Migdal et al, 1994; Musch 2009). In fact, surgery hastens cataract formation, may necessitate (Musch 2009; AGIS group, 2000). equipment, proper operating theatre, experienced surgeon increase cost filtration invasiveness procedure interrupts natural defence mechanism eye, increasing risk infection. Laser less invasive associated with lower Similar surgery, it permanent does require high technology environment requires expensive highmaintenance machine. However, effect insufficient temporary (Glaucoma Trial Research Group, 1995). Manipulation production mainstay topical medications. Topical medications are widely available in industrialised nations, noninvasive easily transportable. addition, they relatively easy instil need for special equipment or environment. Importantly, unlike non-permanent discontinued if ineffective produces unwanted side effects. pressure lowering was previously known as antiglaucoma drugs. many glaucomatologist deem term inappropriate. do at reverse condition totally halt progression glaucoma. this chapter, drugs will be used. sprouting new more effective has widened choice time cause difficulty selection medication. Table 1.0 provide overview on commonly medication market currently. A guideline discussed chapter.